Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma.

Abstract:

:Multiple myeloma (MM) is associated with severe normochromic/normocytic anemia. This study demonstrates that the abnormal up-regulation of apoptogenic receptors, including both Fas ligand (L) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), by highly malignant myeloma cells is involved in the pathogenesis of the ineffective erythropoiesis and chronic exhaustion of the erythroid matrix. By measuring Fas-L and TRAIL in plasma cells and the content of glycophorin A (GpA) in erythroblasts from a cohort of 28 untreated, newly diagnosed patients with MM and 7 with monoclonal gammopathy of undetermined significance (MGUS), selected in relation to their peripheral hemoglobin values, results showed that both receptors occurred at high levels in 15 severely anemic MM patients. Their marrow erythropoietic component was low and included predominantly immature GpA(+dim) erythroblasts, in contrast with the higher relative numbers of mature GpA(+bright) erythroid cells observed in the nonanemic patients and those with MGUS. In cocultures with autologous Fas-L(+)/TRAIL(+) myeloma cells, the expanded GpA(+dim) erythroid population underwent prompt apoptosis after direct exposure to malignant plasma cells, whereas erythroblasts from nonanemic patients were scarcely affected. The evidence that Fas-L(+)/TRAIL(+) malignant plasma cells prime erythroblast apoptosis by direct cytotoxicity was also supported by the increase of FLICE in fresh immature GpA(+dim) erythroid cells, whereas ICE and caspase-10 increased in subsequent maturative forms. In addition, GATA-1, a survival factor for erythroid precursors, was remarkably down-regulated in fresh erythroblasts from the severely anemic patients. These results indicate that progressive destruction of the erythroid matrix in aggressive MM is due to cytotoxic mechanisms based on the up-regulation in myeloma cells of Fas-L, TRAIL, or both. It is conceivable that the altered regulation of these receptors defines a peculiar cytotoxic phenotype that drives the progression of aggressive MM.

journal_name

Blood

journal_title

Blood

authors

Silvestris F,Cafforio P,Tucci M,Dammacco F

doi

10.1182/blood.v99.4.1305

subject

Has Abstract

pub_date

2002-02-15 00:00:00

pages

1305-13

issue

4

eissn

0006-4971

issn

1528-0020

journal_volume

99

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Defective homing is associated with altered Cdc42 activity in cells from patients with Fanconi anemia group A.

    abstract::Previous studies showed that Fanconi anemia (FA) murine stem cells have defective reconstitution after bone marrow (BM) transplantation. The mechanism underlying this defect is not known. Here, we report defective homing of FA patient BM progenitors transplanted into mouse models. Using cells from patients carrying mu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-03-147090

    authors: Zhang X,Shang X,Guo F,Murphy K,Kirby M,Kelly P,Reeves L,Smith FO,Williams DA,Zheng Y,Pang Q

    更新日期:2008-09-01 00:00:00

  • Why "R" HIT patients predisposed to thrombosis?

    abstract::In this issue of Blood, Rollin et al demonstrate that heparin-induced thrombocytopenia and thrombosis (HIT) patients homozygous for arginine (R) at position 131 in the immunoglobulin (Ig)G receptor FcγRIIA have a significantly higher incidence of thrombosis, and show that plasma IgG may play a key role in modulating t...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-02-629782

    authors: Padmanabhan A

    更新日期:2015-04-09 00:00:00

  • beta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation.

    abstract::Control of intensity and duration of erythropoietin (Epo) signaling is necessary to tightly regulate red blood cell production. We have recently shown that the ubiquitin/proteasome system plays a major role in the control of Epo-R signaling. Indeed, after Epo stimulation, Epo-R is ubiquitinated and its intracellular p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-10-055350

    authors: Meyer L,Deau B,Forejtníková H,Duménil D,Margottin-Goguet F,Lacombe C,Mayeux P,Verdier F

    更新日期:2007-06-15 00:00:00

  • In vitro-differentiated T/natural killer-cell progenitors derived from human CD34+ cells mature in the thymus.

    abstract::Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is a treatment option for patients with hematopoietic malignancies that is hampered by treatment-related morbidity and mortality, in part the result of opportunistic infections, a direct consequence of delayed T-cell recovery. Thymic output can be imp...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-05-223990

    authors: Meek B,Cloosen S,Borsotti C,Van Elssen CH,Vanderlocht J,Schnijderberg MC,van der Poel MW,Leewis B,Hesselink R,Manz MG,Katsura Y,Kawamoto H,Germeraad WT,Bos GM

    更新日期:2010-01-14 00:00:00

  • Vitamin D receptor-mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis.

    abstract::Myelofibrosis in myeloproliferative neoplasms (MPNs) with mutations such as JAK2V617F is an unfavorable sign for uncontrollable disease progression in the clinic and is complicated with osteosclerosis whose pathogenesis is largely unknown. Because several studies have revealed that macrophages are an indispensable sup...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-09-876615

    authors: Wakahashi K,Minagawa K,Kawano Y,Kawano H,Suzuki T,Ishii S,Sada A,Asada N,Sato M,Kato S,Shide K,Shimoda K,Matsui T,Katayama Y

    更新日期:2019-04-11 00:00:00

  • Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum.

    abstract::Intracellular protein transport in endothelial cells is selectively inhibited by homocysteine, a thiol amino acid associated with both thrombosis and atherosclerosis. In a previous study, homocysteine decreased cell surface expression of the surface transmembrane glycoprotein thrombomodulin without decreasing secretio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lentz SR,Sadler JE

    更新日期:1993-02-01 00:00:00

  • Allogeneic marrow grafting for treatment of aplastic anemia: a follow-up on long-term survivors.

    abstract::Eleven of twenty-four patients with severe aplastic anemia given marrow grafts from HLA-identical siblings between October 1970 and March 1973 are alive with normal marrow function and continued evidence of engraftment 3-5 yr later. Ten have been leading normal lives with no immunosuppressive or other drug therapy sin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Storb R,Thomas ED,Buckner CD,Clift RA,Fefer A,Fernando LP,Giblett ER,Johnson FL,Neiman PE

    更新日期:1976-10-01 00:00:00

  • Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias.

    abstract::The t(11;14)(q13;q32) translocation and its molecular counterpart, BCL-1 rearrangement, are consistent features of intermediate lymphocytic lymphoma (ILL). Rearrangement is thought to deregulate the nearby PRAD-1/BCL-1 proto-oncogene that is a newly identified member of the cyclin family. To characterize further the a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rimokh R,Berger F,Delsol G,Charrin C,Berthéas MF,Ffrench M,Garoscio M,Felman P,Coiffier B,Bryon PA

    更新日期:1993-06-01 00:00:00

  • How I treat MDS and AML in Fanconi anemia.

    abstract::Fanconi anemia (FA) is the most frequent inherited cause of bone marrow failure (BMF). Most FA patients experience hematopoietic stem cell attrition and cytopenia during childhood, which along with intrinsic chromosomal instability, favor clonal evolution and the frequent emergence in their teens or young adulthood of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-01-583625

    authors: Peffault de Latour R,Soulier J

    更新日期:2016-06-16 00:00:00

  • The BRISC deubiquitinating enzyme complex limits hematopoietic stem cell expansion by regulating JAK2 K63-ubiquitination.

    abstract::Hematopoietic stem cell (HSC) homeostasis is controlled by cytokine receptor-mediated Janus kinase 2 (JAK2) signaling. We previously found that JAK2 is promptly ubiquitinated upon cytokine stimulation. Whether a competing JAK2 deubiquitination activity exists is unknown. LNK is an essential adaptor protein that constr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-10-877563

    authors: Donaghy R,Han X,Rozenova K,Lv K,Jiang Q,Doepner M,Greenberg RA,Tong W

    更新日期:2019-04-04 00:00:00

  • Bone modulation in sustained hematopoietic stimulation in mice.

    abstract::To understand the etiology of bone modulation and hypercalcemia observed in granulocytosis of a tumor-bearing animal model and to gain insight into the implication of sustained hematopoietic stimulation on the bone tissue, in vivo responses of normal mouse hematopoietic and bone tissues to long-term injections of reco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lee MY,Fukunaga R,Lee TJ,Lottsfeldt JL,Nagata S

    更新日期:1991-05-15 00:00:00

  • Inhibition of cellular differentiation by the SCL/tal oncoprotein: transcriptional repression by an Id-like mechanism.

    abstract::In cases of T-cell acute lymphoblastic leukemia (T-ALL), the basic helix-loop-helix (bHLH) oncogene SCL/tal undergoes frequent rearrangements activating ectopic expression. Despite the compelling epidemiological association of SCL/tal expression with T-ALL, no specific transforming function has been attributable to th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Goldfarb AN,Lewandowska K

    更新日期:1995-01-15 00:00:00

  • HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma.

    abstract::We have shown that human B-cell non-Hodgkin lymphomas (B-NHLs) express heat shock protein (HSP)H1/105 in function of their aggressiveness. Here, we now clarify its role as a functional B-NHL target by testing the hypothesis that it promotes the stabilization of key lymphoma oncoproteins. HSPH1 silencing in 4 models of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-590034

    authors: Zappasodi R,Ruggiero G,Guarnotta C,Tortoreto M,Tringali C,Cavanè A,Cabras AD,Castagnoli L,Venerando B,Zaffaroni N,Gianni AM,De Braud F,Tripodo C,Pupa SM,Di Nicola M

    更新日期:2015-03-12 00:00:00

  • Defective tubulin organization and proplatelet formation in murine megakaryocytes lacking Rac1 and Cdc42.

    abstract::Blood platelets are anuclear cell fragments that are essential for blood clotting. Platelets are produced by bone marrow megakaryocytes (MKs), which extend protrusions, or so-called proplatelets, into bone marrow sinusoids. Proplatelet formation requires a profound reorganization of the MK actin and tubulin cytoskelet...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-03-487942

    authors: Pleines I,Dütting S,Cherpokova D,Eckly A,Meyer I,Morowski M,Krohne G,Schulze H,Gachet C,Debili N,Brakebusch C,Nieswandt B

    更新日期:2013-10-31 00:00:00

  • Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia.

    abstract::Fifty-one children with acute lymphoblastic leukemia (ALL) in second or subsequent remission after a first remission of at least 24 months underwent purged, autologous bone marrow transplantation (ABMT). Bone marrow was harvested in remission and purged in vitro with monoclonal antibodies specific for leukemia-associa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Billett AL,Kornmehl E,Tarbell NJ,Weinstein HJ,Gelber RD,Ritz J,Sallan SE

    更新日期:1993-03-15 00:00:00

  • Blood tests for the diagnosis of venous and arterial thrombosis.

    abstract::There are many reports in the literature of blood test abnormalities occurring in patients with venous or arterial thrombosis. Most of these have not used acceptable criteria for establishing an association between thrombosis and blood tests and, therefore, their interpretation is questionable. Recently, sensitive and...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Hirsh J

    更新日期:1981-01-01 00:00:00

  • Rh blood group-specific antibodies in immune hemolytic anemia induced by nomifensine.

    abstract::Nomifensine (Merital, Alival; Hoechst, Frankfurt, FRG), an antidepressant drug, may cause immune hemolytic anemia (IHA) of the so-called immune complex type that is believed to occur by means of an innocent-bystander mechanism. In this report we describe findings that are not consistent with this mechanism in a patien...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Salama A,Mueller-Eckhardt C

    更新日期:1986-12-01 00:00:00

  • Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells.

    abstract::The c-kit proto-oncogene encodes a receptor tyrosine kinase that is thought to play an important role in hematopoiesis. In a series of human acute myeloblastic leukemia (AML), the expression of the c-kit proto-oncogene and its product was studied by means of Northern blot and immunoblot analyses. The c-kit mRNA was ex...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ikeda H,Kanakura Y,Tamaki T,Kuriu A,Kitayama H,Ishikawa J,Kanayama Y,Yonezawa T,Tarui S,Griffin JD

    更新日期:1991-12-01 00:00:00

  • The chronic myeloid leukemia stem cell: stemming the tide of persistence.

    abstract::Chronic myeloid leukemia (CML) is caused by the acquisition of the tyrosine kinase BCR-ABL1 in a hemopoietic stem cell, transforming it into a leukemic stem cell (LSC) that self-renews, proliferates, and differentiates to give rise to a myeloproliferative disease. Although tyrosine kinase inhibitors (TKIs) that target...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-09-696013

    authors: Holyoake TL,Vetrie D

    更新日期:2017-03-23 00:00:00

  • HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells.

    abstract::Hypoxia-inducible factor-1α (HIF1α), a master transcriptional regulator of the cellular and systemic hypoxia response, is essential for the maintenance of self-renewal capacity of normal HSCs. It is still unknown whether HIF1α has a role in survival regulation of leukemia stem cells (LSCs) in chronic myeloid leukemia ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-387381

    authors: Zhang H,Li H,Xi HS,Li S

    更新日期:2012-03-15 00:00:00

  • Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia.

    abstract::Sixteen patients treated by allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) were evaluated by the polymerase chain reaction (PCR) for bcr/abl-specific RNA transcripts at various time points after BMT. In reconstitution experiments, one CML cell per million normal mononuclear cells c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Roth MS,Antin JH,Bingham EL,Ginsburg D

    更新日期:1989-08-01 00:00:00

  • Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination.

    abstract::The recent success of chimeric antigen receptor (CAR)-T cell therapy for treatment of hematologic malignancies supports further development of treatments for both liquid and solid tumors. However, expansion of CAR-T cell therapy is limited by the availability of surface antigens specific for the tumor while sparing no...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-08-802926

    authors: Akahori Y,Wang L,Yoneyama M,Seo N,Okumura S,Miyahara Y,Amaishi Y,Okamoto S,Mineno J,Ikeda H,Maki T,Fujiwara H,Akatsuka Y,Kato T,Shiku H

    更新日期:2018-09-13 00:00:00

  • The shortest isoform of C/EBPβ, liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model.

    abstract::Ecotropic viral integration site 1 (Evi1) is one of the master regulators in the development of acute myeloid leukemia (AML) and myelodysplastic syndrome. High expression of Evi1 is found in 10% of patients with AML and indicates a poor outcome. Several recent studies have indicated that Evi1 requires collaborative fa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-07-368654

    authors: Watanabe-Okochi N,Yoshimi A,Sato T,Ikeda T,Kumano K,Taoka K,Satoh Y,Shinohara A,Tsuruta T,Masuda A,Yokota H,Yatomi Y,Takahashi K,Kitaura J,Kitamura T,Kurokawa M

    更新日期:2013-05-16 00:00:00

  • Selective inhibition of spontaneous IgE and IgG4 production by interleukin-8 in atopic patients.

    abstract::The effects of interleukin (IL)-8 on spontaneous IgE and IgG4 production in atopic patients were studied. IL-8 inhibited IgE and IgG4 production by purified surface (s) IgE+ and sIgG4+ B cells, respectively, while it had no effect on IgG1, IgG2, IgG3, IgM, IgA1, and IgA2 production by corresponding sIg+ B cells. The I...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kimata H,Lindley I,Furusho K

    更新日期:1995-06-01 00:00:00

  • In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes.

    abstract::Anticoagulation with vitamin K antagonists (VKAs) is problematic because of difficulties in safely managing dosing. Polymorphisms in cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase genes (VKORC1) have been shown to affect VKA dosing in adults. The association of these polymorphisms on VKA dosing in childr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-05-283861

    authors: Nowak-Göttl U,Dietrich K,Schaffranek D,Eldin NS,Yasui Y,Geisen C,Mitchell LG

    更新日期:2010-12-23 00:00:00

  • Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production.

    abstract::Interleukin-33 (IL-33), a member of the IL-1 cytokine family, is emerging as a new regulator of immune responses and inflammatory vascular diseases. Although IL-33 and its cognate receptor ST2 appear to be expressed in vascular cells, the precise role of IL-33 in the vasculature has not been determined. In this study,...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-203372

    authors: Choi YS,Choi HJ,Min JK,Pyun BJ,Maeng YS,Park H,Kim J,Kim YM,Kwon YG

    更新日期:2009-10-01 00:00:00

  • Minor viral and host genetic polymorphisms can dramatically impact the biologic outcome of an epitope-specific CD8 T-cell response.

    abstract::Human immunodeficiency virus-1 subtypes A and C differ in the highly conserved Gag-TL9 epitope at a single amino acid position. Similarly, the TL9 presenting human leukocyte antigen (HLA) class I molecules B42 and B81 differ only at 6 amino acid positions. Here, we addressed the influence of such minor viral and host ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-206193

    authors: Geldmacher C,Metzler IS,Tovanabutra S,Asher TE,Gostick E,Ambrozak DR,Petrovas C,Schuetz A,Ngwenyama N,Kijak G,Maboko L,Hoelscher M,McCutchan F,Price DA,Douek DC,Koup RA

    更新日期:2009-08-20 00:00:00

  • Localization of ADAMTS13 to the stellate cells of human liver.

    abstract::Although the chromosomal localization (9q34) of the gene encoding the human form of ADAMTS13 (a disintegrin-like and metalloproteinase with thrombospondin type-1 motifs 13) and its exclusive expression in the liver have been established, the cells that produce this enzyme are yet to be determined. We investigated the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-01-0152

    authors: Uemura M,Tatsumi K,Matsumoto M,Fujimoto M,Matsuyama T,Ishikawa M,Iwamoto TA,Mori T,Wanaka A,Fukui H,Fujimura Y

    更新日期:2005-08-01 00:00:00

  • Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease.

    abstract::Autologous stem-cell transplantation has become a widely used therapy in Hodgkin's disease (HD). To appreciate the early and late risks associated with this procedure, its lethal toxicity and effects on the incidence of secondary cancers were studied. Data related to 467 French patients grafted from 1982 to 1995 for p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: André M,Henry-Amar M,Blaise D,Colombat P,Fleury J,Milpied N,Cahn JY,Pico JL,Bastion Y,Kuentz M,Nedellec G,Attal M,Fermé C,Gisselbrecht C

    更新日期:1998-09-15 00:00:00

  • Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans.

    abstract::Endotoxin is a component of gram-negative bacteria that causes hematologic and immunologic changes through its induction of cytokines. Interleukin-1 receptor antagonist (IL-1Ra) is a naturally occurring inhibitor of IL-1 that competes with IL-1 for occupancy of cell-surface receptors but possesses no agonist activity....

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Granowitz EV,Porat R,Mier JW,Orencole SF,Callahan MV,Cannon JG,Lynch EA,Ye K,Poutsiaka DD,Vannier E

    更新日期:1993-11-15 00:00:00